Sofinnova Ventures as of June 30, 2018
Portfolio Holdings for Sofinnova Ventures
Sofinnova Ventures holds 58 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A S (ASND) | 18.7 | $165M | 2.5M | 66.52 | |
| Nucana Biomed ordinary shares | 8.6 | $76M | 4.0M | 19.00 | |
| Obseva Sa | 8.1 | $72M | 4.7M | 15.14 | |
| Natera (NTRA) | 6.6 | $58M | 3.1M | 18.82 | |
| Merus N V (MRUS) | 5.0 | $45M | 2.0M | 22.76 | |
| Coherus Biosciences (CHRS) | 4.6 | $41M | 2.9M | 14.00 | |
| Spark Therapeutics | 4.5 | $40M | 481k | 82.76 | |
| Audentes Therapeutics | 4.0 | $36M | 934k | 38.21 | |
| Aclaris Therapeutics (ACRS) | 3.5 | $31M | 1.5M | 19.97 | |
| Iterum Therapeutics | 2.1 | $19M | 1.7M | 10.89 | |
| Allergan | 2.1 | $19M | 112k | 166.75 | |
| Alexion Pharmaceuticals | 2.0 | $18M | 141k | 124.16 | |
| Kiniksa Pharmaceuticals (KNSA) | 1.8 | $16M | 923k | 17.35 | |
| Celgene Corporation | 1.7 | $15M | 184k | 79.42 | |
| Apellis Pharmaceuticals (APLS) | 1.5 | $14M | 616k | 22.00 | |
| Nucana Plc american depositary shares (NCNA) | 1.4 | $13M | 667k | 19.00 | |
| Amarin series a preferred | 1.4 | $12M | 3.9M | 3.09 | |
| Crispr Therapeutics (CRSP) | 1.3 | $12M | 200k | 58.74 | |
| AstraZeneca (AZN) | 1.3 | $12M | 330k | 35.11 | |
| Amarin Corporation (AMRN) | 1.2 | $10M | 3.3M | 3.09 | |
| Heron Therapeutics (HRTX) | 1.1 | $10M | 259k | 38.85 | |
| Aimmune Therapeutics | 1.1 | $10M | 375k | 26.89 | |
| Intercept Pharmaceuticals In | 1.0 | $9.0M | 107k | 83.87 | |
| Gw Pharmaceuticals Plc ads | 1.0 | $8.8M | 63k | 139.60 | |
| Bluebird Bio (BLUE) | 1.0 | $8.7M | 55k | 157.00 | |
| Adamas Pharmaceuticals | 0.8 | $7.3M | 283k | 25.83 | |
| Kadmon Hldgs | 0.8 | $7.1M | 1.8M | 3.99 | |
| Rigel Pharmaceuticals (RIGL) | 0.7 | $6.4M | 2.3M | 2.83 | |
| Sarepta Therapeutics (SRPT) | 0.7 | $6.4M | 48k | 132.17 | |
| Esperion Therapeutics (ESPR) | 0.7 | $5.9M | 151k | 39.18 | |
| Blueprint Medicines (BPMC) | 0.7 | $5.9M | 92k | 63.48 | |
| Synlogic | 0.6 | $5.7M | 575k | 9.83 | |
| Histogenics Corp Cmn | 0.6 | $5.2M | 2.1M | 2.50 | |
| Clearside Biomedical (CLSD) | 0.5 | $4.6M | 433k | 10.69 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.5 | $4.5M | 1.4M | 3.12 | |
| Rhythm Pharmaceuticals (RYTM) | 0.5 | $4.4M | 140k | 31.28 | |
| Ptc Therapeutics I (PTCT) | 0.5 | $4.3M | 127k | 33.73 | |
| Kala Pharmaceuticals | 0.5 | $4.2M | 303k | 13.74 | |
| Otonomy | 0.4 | $3.8M | 980k | 3.85 | |
| Conatus Pharmaceuticals | 0.4 | $3.7M | 859k | 4.28 | |
| Puma Biotechnology (PBYI) | 0.4 | $3.7M | 62k | 59.21 | |
| Spectrum Pharmaceuticals | 0.4 | $3.6M | 170k | 20.99 | |
| Foamix Pharmaceuticals | 0.4 | $3.4M | 682k | 5.01 | |
| Dermira | 0.4 | $3.3M | 364k | 9.19 | |
| Reata Pharmaceuticals Inc Cl A | 0.4 | $3.1M | 90k | 34.92 | |
| Kura Oncology (KURA) | 0.3 | $3.1M | 168k | 18.21 | |
| Edge Therapeutics | 0.3 | $2.9M | 2.9M | 1.03 | |
| Savara (SVRA) | 0.3 | $2.9M | 257k | 11.31 | |
| AMAG Pharmaceuticals | 0.3 | $2.8M | 143k | 19.53 | |
| Chiasma | 0.3 | $2.7M | 1.8M | 1.50 | |
| Aduro Biotech | 0.2 | $1.7M | 241k | 7.00 | |
| Calithera Biosciences | 0.2 | $1.5M | 297k | 5.00 | |
| Chemocentryx | 0.1 | $899k | 68k | 13.17 | |
| Oncomed Pharmaceuticals | 0.1 | $915k | 396k | 2.31 | |
| Syndax Pharmaceuticals (SNDX) | 0.1 | $694k | 99k | 7.04 | |
| Innate Pharma Sa Class A - F S | 0.1 | $602k | 111k | 5.43 | |
| Forty Seven | 0.0 | $379k | 24k | 15.97 | |
| Auris Medical Newco Holding Ag Namen-akt Isin Ch0408330303 | 0.0 | $0 | 140k | 0.00 |
